Cx Institutional Catalent, Inc. Transaction History

Cx Institutional

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$87.2 - $114.05 $30,345 - $39,689	348 New	348 $37,000
Q4 2021 Jan 18, 2022	SELL	$119.57 - $139.07 $25,827 - $30,039	-216 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$109.17 - $142.35 $2,292 - $2,989	21 Added 10.77%	216 $29,000
Q2 2021 Aug 04, 2021	BUY	$100.34 - $115.69 $10,335 - $11,916	103 Added 111.96%	195 $21,000
Q1 2021 Apr 15, 2021	BUY	$101.51 - $125.27 $1,928 - $2,380	19 Added 26.03%	92 $10,000
Q4 2020 Jan 12, 2021	BUY	$85.88 - $105.36 $3,778 - $4,635	44 Added 151.72%	73 $8,000
Q3 2020 Oct 13, 2020	BUY	$72.74 - $92.5 $654 - $832	9 Added 45.0%	29 $2,000
Q2 2020 Aug 06, 2020	BUY	$48.02 - $79.04 $960 - $1,580	20 New	20 $1,000
Q3 2019 Oct 10, 2019	SELL	$47.45 - $58.05 $1,423 - $1,741	-30 Closed	0 $0
Q2 2019 Jul 17, 2019	BUY	$39.26 - $54.21 $1,177 - $1,626	30 New	30 $2,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

Stay updated on Cx Institutional with notifications on news.